222.94
Bio Rad Laboratories Inc (BIO) 最新ニュース
Food Diagnostics Market | Rapid Pathogen & Contaminant - openPR.com
Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment - GlobeNewswire Inc.
Cancer Monoclonal Antibodies Market in 2025-2032 Detailed - openPR.com
Next Generation Sequencing Market to Witness Upsurge in Growth - openPR.com
bio-rad laboratories stock highlighted in cantor fitzgerald report - Investing.com Australia
Laboratory Proficiency Testing Market Set to Witness - openPR.com
Minimal Residual Disease Testing Market Set to Witness - openPR.com
bio-rad laboratories stock highlighted in cantor fitzgerald report By Investing.com - Investing.com UK
Enzyme Linked Immunosorbent Assay Market reached US$ 2.14 - openPR.com
Flow Cytometry Market Growth, Trends & Forecast 2025 | Global - openPR.com
Immunohistochemistry Market Detailed in New Research Report - openPR.com
Here’s Why Bio-Rad Laboratories (BIO) Traded Lower in Q1 - Insider Monkey
Global Microarray Market Size, Share & Growth Forecast - openPR.com
How DNA Sequencing Is Revolutionizing Cancer Genomics and Rare - openPR.com
Cell Viability Assays Market 2025 | Techniques, Applications & - openPR.com
High Resolution Melting Analysis Market Detailed in New - openPR.com
Gel Documentation Systems Market Projected to Witness Massive - openPR.com
Cell Signaling Market in 2025-2032 Detailed Study Analysis with - openPR.com
Neuroscience Antibodies and Assays Market Trends, Growth & - openPR.com
Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Learn to Evaluate (BIO) using the Charts - news.stocktradersdaily.com
Bio-Rad Laboratories (NYSE:BIO) Stock Rating Upgraded by Wall Street Zen - Defense World
Protein Characterization and Identification Market Is Booming WorldwideBio-Rad Laboratories, Agilent Technologies - openPR.com
Electrophoresis Reagents Market Detailed in New Research ReportBio-Rad Laboratories, Thermo Fisher Scientific - openPR.com
Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference | BIO Stock News - GuruFocus
Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference - Business Wire
Syphilis Market Growth Projections 2023-2032: DelveInsight - openPR.com
Cell Analysis Market Deep Research Report Highlights New DevelopmentsBD Biosciences, Bio-Rad - openPR.com
Hemoglobin A1c Testing Devices Market To Witness Substantial - openPR.com
Difficult-to-Express Proteins Market Expansion Driven - openPR.com
Salmonella Testings Market to Witness Stunning Growth with Thermo Fisher, Bio-Rad, Merck - openPR.com
Flow Cytometry Market Deep Research with Forecast By 2025-2032 | - openPR.com
Protein Assays Market Set to Witness Significant Growth - openPR.com
Nuveen Asset Management LLC Increases Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Enzyme Linked Immunosorbent Assay Market Survey Detailed - openPR.com
Global Clinical Microbiology Market Trends, Growth & Analysis - openPR.com
Zacks Research Issues Negative Forecast for BIO Earnings - Defense World
Zacks Research Has Positive Outlook of BIO FY2027 Earnings - Defense World
Medical Biosensors Market 2025 | Latest Trends, Growth Forecast - openPR.com
Bio-Rad’s SWOT analysis: life science firm navigates tariffs, eyes growth - Investing.com Canada
Bio-Rad at RBC Healthcare Conference: Strategic Focus Amid Challenges - Investing.com Australia
Bio-Rad at RBC Healthcare Conference: Strategic Focus Amid Challenges By Investing.com - Investing.com Nigeria
Transcript : Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 01 - marketscreener.com
Bio-Rad Laboratories Inc (BIO) Stock Price Down 4.42% on May 21 - GuruFocus
大文字化:
|
ボリューム (24 時間):